Parotid gland function after radiotherapy: the combined michigan and utrecht experience. - Wikidata - awgldk - TriplyDB

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

http://www.wikidata.org/entity/Q33927574

about

Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment Initial evaluation of automated treatment planning software Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.Integrated multicriterial optimization of beam angles and intensity profiles for coplanar and noncoplanar head and neck IMRT and implications for VMAT.Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose-response relationship of parotid-sparing radiotherapy in head-neck cancers.Automatic interactive optimization for volumetric modulated arc therapy planning.Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?Improving IMRT-plan quality with MLC leaf position refinement post plan optimization.Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.Recombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomia A Nomogram to predict parotid gland overdose in head and neck IMRT Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.Salivary gland sparing in the treatment of head and neck cancer.Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.Impact of MLC leaf width on volumetric-modulated arc therapy planning for head and neck cancers.Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.Evaluation of deformable image registration methods for dose monitoring in head and neck radiotherapy.Cone-beam computed tomography (CBCT) for adaptive image guided head and neck radiation therapy.Predicting Patient-specific Dosimetric Benefits of Proton Therapy for Skull-base Tumors Using a Geometric Knowledge-based Method.Exploratory study of long-term health-related quality of life in patients with surgically treated primary parotid gland cancer.Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy.Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans.Tyrosine Kinase Inhibitors Protect the Salivary Gland from Radiation Damage by Inhibiting Activation of Protein Kinase C-δ.Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images.Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.

P2860

Q26849735-4308D118-A4EF-410A-B693-8C27CF214AE0 Q28275470-52616FB3-DE52-4C95-BB2C-B6C41F4B52FB Q30402671-46970343-DD62-4ECC-A17C-BC36CD56E0A9 Q34242059-029F1C55-00C6-4EDF-A16C-2B7E183D1D5B Q34380405-249EA06A-9E7C-4A93-8129-12A46E58F936 Q34498711-E1CB3EE4-4D15-4B7B-8F86-5A946D9DB003 Q34564948-A1A2896C-AE37-4BB3-B6E8-4758AC3F7AEE Q35030231-3E03E2BA-72A6-4EBE-9229-E489BFA3EE18 Q35215496-2B3E7142-DFF0-45E9-9A08-9B85693796A9 Q35380127-95AD3FBE-D58E-438C-B9C1-7454B7EAB60C Q35683086-7AB09AA7-86F4-4428-8B50-8B54B96718C8 Q35846257-240EA297-6251-40A3-9AE8-6B0D5667738E Q36157062-3C784F44-0FC8-41F9-A3C5-BFFB0302167B Q36317335-BDC0C044-E9A5-4E60-907D-BDC031A7C8C9 Q36626509-E2D5F635-291B-4039-85F1-334E2249589C Q36945801-17D2B60D-C64D-4D6C-B99A-11CA561A88DB Q36982165-67CE2CA6-2A54-4333-A53E-948188577913 Q37248648-CBEE5C9D-9884-468E-A373-28E970C41638 Q37686456-A7A2054D-C3CB-4E87-8898-114423F530EA Q37934975-8828B959-E0A8-451F-B4BF-C30504D9F71A Q38381626-27F702CB-9847-444A-BAC2-6C84B95E6184 Q38423518-C1193815-26E1-41A4-BF48-09DC92C873F3 Q38733003-F27F4791-70DE-4EFF-BBB2-F75EFDBD67A0 Q41897016-531ACC89-3DFF-4E4E-8644-B01399C3299F Q42058253-AFBFB67E-6DB1-4A1E-A7CD-86F6FDFBF6B9 Q47613010-6C9E6605-9CEA-436E-8CDE-64B482E2DF94 Q47918978-71B5FBA5-C704-43C7-9278-2EDDBE781DCF Q48065416-699ED617-D2A6-4327-8E16-0A92FEDB4101 Q48203844-56FDC2D2-2F8E-418B-A506-3467E1820278 Q50864932-60E8360D-9377-46BF-BEC2-835FF49B6213 Q50931131-5CD01C04-0BA8-4B81-B1DE-462B989E66C3 Q51696197-65FAD0C9-EF65-411F-A798-CC9F2DF21148 Q52856838-6250934F-797F-40C3-BFBC-400F5BE0FAFC Q52943696-57F9FD25-A8B2-4958-B1AB-0FA0A0FF3A94 Q55332889-74A5C05F-1A90-48CB-AA4C-5A7E5D3DCDA7

P2860

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

http://www.wikidata.org/entity/Q33927574

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@ast

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@en

type

label

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@ast

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@en

prefLabel

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@ast

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@en

P1433

Q33927574-ED45C49D-2097-4D19-8D9B-3EAF0DC3810B

P1476

Q33927574-6B86A0DB-27D2-4C8C-AA4C-B2CC06A675AC

P2093

Q33927574-237CC8D9-F0F1-4865-8362-CB37F326CD82

Q33927574-53E532C9-B3F9-4D1E-BDB0-C91018DD6AB2

Q33927574-79624F6F-6D26-4BA0-93F7-78EB798ECF9E

Q33927574-A403D9E4-A5B9-4C2C-A7A8-EDCC7930CBC7

Q33927574-AB8040AE-65BB-40CB-B7BD-B0C52080EBDB

Q33927574-BDB8F7A3-1568-4755-899C-746A046A4C2B

Q33927574-E477E0FC-444F-4A5B-9CEA-077DD2ED324A

Q33927574-F68FEF5F-EF4D-4DCB-AD82-511754396B9B

P2860

Q33927574-07108956-B2F4-4686-A280-165C8806AD89

Q33927574-13BD86DA-D006-4F32-93C7-D57F95A3F198

Q33927574-2C520306-4EF7-4675-824E-875288E800E5

Q33927574-36883B4B-D2DD-4B59-8886-D35E5BDA5290

Q33927574-50B9265C-3129-4BC0-BCA9-C3BA9696E851

Q33927574-6F9AD0C4-C943-4F62-B3C5-4E432D76CA3A

Q33927574-83FC3A2C-AE18-4956-9C52-BED705239D8C

Q33927574-B5E03AA4-50CF-4A77-8031-66D38437F46F

Q33927574-BE37DC5B-042A-49C3-A387-B0142F49DC53

Q33927574-D559B069-3D90-4462-AF25-52B91F2B699C

P304

Q33927574-6FC8C8BE-22BE-4598-825C-8EB3B6FEA11F

P31

Q33927574-F65F86A1-6CF5-4B2B-9E9F-9331AF3D2D8D

P356

Q33927574-B9E5212D-663F-4766-BC5F-123C8DA77ED8

P407

Q33927574-1ACAF351-36A9-456B-AD43-10A024361AD2

P433

Q33927574-440F1E57-DC92-4993-BA9C-98DB9E5A51BB

P478

Q33927574-FBD99B78-D7A2-4CC2-89F3-366FFBCD790E

P50

Q33927574-0BC2399D-4A8B-4A0D-8A65-2A2792ED8455

P577

Q33927574-8968082B-2C2D-4C30-AD09-00FAA6494F39

P5875

Q33927574-D6FAFEF1-48F8-4FC1-96DD-B30B7D22BFCA

P698

Q33927574-A19880DF-73E5-4AE0-A21E-FDCD7D0CDFFB

P921

Q33927574-B0A063CF-44F3-47C4-955A-568F948E0AC8

P932

Q33927574-6C1D6C58-89A8-48E1-B0B9-B54D6D2708A6

P356

J.IJROBP.2009.07.1708

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

@en

P2093

Anette C Houweling

http://www.w3.org/2001/XMLSchema#string

Chris H J Terhaard

http://www.w3.org/2001/XMLSchema#string

Cornelis P J Raaijmakers

http://www.w3.org/2001/XMLSchema#string

Judith M Roesink

http://www.w3.org/2001/XMLSchema#string

Marinus A Moerland

http://www.w3.org/2001/XMLSchema#string

Pètra M Braam

http://www.w3.org/2001/XMLSchema#string

Randall K Ten Haken

http://www.w3.org/2001/XMLSchema#string

Tim Dijkema

http://www.w3.org/2001/XMLSchema#string

P2860

A modified poisson regression approach to prospective studies with binary data

The controversies and pitfalls in modeling normal tissue radiation injury/damage.

Partial irradiation of the parotid gland.

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials.

Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy.

Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland.

Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

P304

449-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2009.07.1708

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Avraham Eisbruch

P577

2010-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40894330

http://www.w3.org/2001/XMLSchema#string

P698

20056347

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2889151

http://www.w3.org/2001/XMLSchema#string